Kits Eyecare Ltd.

Equities

KITS

CA49804N1042

Other Specialty Retailers

Market Closed - Toronto S.E. 05:00:00 2024-03-27 pm EDT 5-day change 1st Jan Change
6.15 CAD -0.97% Intraday chart for Kits Eyecare Ltd. -5.09% -1.44%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Kits Eyecare Promotes Zhe Choo to Chief Financial Officer Role MT
KITS Eyecare Brief: Naming Zhe Choo Chief Financial Officer MT
Kits Eyecare Ltd. Appoints Zhe Choo as Chief Financial Officer, Effective March 31, 2024 CI
Transcript : Kits Eyecare Ltd., Q4 2023 Earnings Call, Mar 06, 2024
Kits Eyecar Narrows Q4 Loss, Revenue Grows MT
Kits Eyecare Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
KITS Eyecare Brief: Q4 Net loss improved to $0.5 million, or $(0.02) per share (basic), compared to a net loss of $1.4 million, or $(0.04) per share (basic), in the prior year period MT
KITS Eyecare Brief: Q4 Revenue increased by 21% to a record $31.7 million compared to $26.2 million MT
North American Morning Briefing : Stock Futures Rise Ahead of Powell's Testimony DJ
Kits Eyecare Initiated at Buy at Stifel GMP; Price Target Set at C$8.00 MT
KITS Eyecare Announces Record Results For Cyber Monday MT
KITS Eyecare Brief: Announcing Record Results for Cyber Monday MT
KITS Eyecare Announces Record Eyeglasses Revenue in Week Leading into Black Friday MT
KITS Eyecare Brief: Announcing Record Eyeglasses Revenue in Week Leading into Black Friday MT
Transcript : Kits Eyecare Ltd., Q3 2023 Earnings Call, Nov 08, 2023
Kits Eyecare Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Kits Eyecare Expands Manufacturing Capacity For Digital Progressive Eyeglasses MT
KITS Eyecare Brief: Expanding Manufacturing Capacity of Digital Progressive Eyeglasses by 50% MT
Kits Eyecare Ltd. Expands Manufacturing Capacity of Digital Progressive Eyeglasses by 50% CI
Kits Eyecare Reports Preliminary Q3 2023 Results MT
Kits Eyecare Ltd.'s Equity Buyback announced on August 25, 2022, has expired. CI
Transcript : Kits Eyecare Ltd., Q2 2023 Earnings Call, Aug 09, 2023
Kits Eyecare Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
KITS Eyecare Brief: Q2 Revenue increased 38% to $30.0 million compared to $21.8 million in the prior year MT
KITS Eyecare Brief: Reporting Preliminary Second Quarter 2023 Results; Q2 Revenue Grew 38% YOY to Approximately $30 Million; Says Cash Balance Remained Healthy at $19.8 Million MT
Chart Kits Eyecare Ltd.
More charts
Kits Eyecare Ltd. is a Canada-based provider of vertically integrated and digitally native eyecare platforms. The Company operates through the sale of eyewear products to consumers. It offers customers access to a selection of contact lenses and eyeglasses, including its own KITS-designed products, as well as an advanced suite of online vision tools. Its collections include South Beach, Little Italy, Trail Blazer, KITS x Vasuma and Apres. The Company's designer glasses and sunglasses, including Alexander Mcqueen, Armourx, Betsey Johnson, Bottega Veneta, Calvin Klein Carrera, David Beckham, Diesel, Dior, Emilio Pucci, Emporio Armani, Gucci, Hugo Boss, Jimmy Choo, Judith Leiber, Kits, Persol, Prada, Ray-Ban, Superdry, Tom Ford, Under Armour, And Versace.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
6.15 CAD
Average target price
9.292 CAD
Spread / Average Target
+51.08%
Consensus
  1. Stock
  2. Equities
  3. Stock Kits Eyecare Ltd. - Toronto S.E.
  4. News Kits Eyecare Ltd.
  5. KITS Eyecare Brief: Adds "Healthy Balance Sheet and Resilient Optical Market" Has It "Well-Positioned for 2023"